Background Chronic obstructive pulmonary disease (COPD) is characterized by irreversible
lung tissue damage. Novel regenerative strategies are urgently awaited. Cultured …

Autologous bone marrow-derived mesenchymal stromal cells (BM-MSCs) are evaluated for
clinical use in chronic obstructive pulmonary disease (COPD) patients, but it is unclear …

Chronic obstructive pulmonary disease (COPD) is an inflammatory airways disease with
limited therapeutic options. We have previously shown that mesenchymal stromal cell (MSC) …

Mesenchymal stromal cells (MSCs) may provide crucial support in the regeneration of
destructed alveolar tissue (emphysema) in chronic obstructive pulmonary disease (COPD) …

Background In the last two decades, mesenchymal stem cells (MSCs) have been pre-
clinically utilized in the treatment of a variety of kinds of diseases including chronic …

Stromal support is critical for lung homeostasis and the maintenance of an effective
epithelial barrier. Despite this, previous studies have found a positive association between …

Background: Macrophages and monocytes orchestrate inflammatory processes in the lungs.
However, their role in the pathogenesis of chronic obstructive pulmonary disease (COPD) …

All adult tissues, including the lung, have some capacity to self‐repair or regenerate through
the replication and differentiation of stem cells resident within these organs. While lung …

Mesenchymal stem cells have been reported to be key mediators of the regeneration and
repair processes in chronic lung diseases (Gallicchio et al. 2019; Cancio et al. 2018) …

Background Chronic obstructive pulmonary disease (COPD) is a prevalent and preventable
condition. Mesenchymal stem cell (MSC) therapy is being explored to aid in the …